# Normast3 for Adults With Diabetic Polyneuropathy

> **NCT07689214** · NA · RECRUITING · sponsor: **University of Roma La Sapienza** · enrollment: 40 (estimated)

## Conditions studied

- Diabete Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** Normast® 3 - a food for special medical purposes (FSMP) containing co-micronized palmitoylethanolamide (PEA) with rutin and hydroxytyrosol. It is designed to support the management of diabetic polyneu
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07689214
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-17
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07689214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07689214, "Normast3 for Adults With Diabetic Polyneuropathy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07689214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*